HBM launches second biotech fund

Swiss-based HBM Bioventures is looking to raise E200m to invest in privately-held businesses in the US and Western Europe.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this